Direct Targeted Methylation Sequencing (gDNA)

About Wasatch BioLabs

Wasatch BioLabs is a specialized service provider in the genetics and genomics sector, built around proprietary long-read sequencing platforms for integrated genomic and epigenomic data. Its core innovation is the Direct Whole Methylome Sequencing (dWMS) platform, which enables bisulfite-free, PCR-free methylation analysis alongside variant detection. Positioning itself as the first full-scale clinical lab dedicated to Oxford Nanopore sequencing, the company targets the high-growth areas of precision health, biomarker discovery, and scalable clinical assay deployment.